Quality of Life - the Primary Component in Senior Health Care

Sign Up

Archive for October, 2014:

October 28th, 2014

Is the Role of Beta-Blockers in Coronary Artery Disease Treatment Changing?

Is the Role of Beta-Blockers in Coronary Artery Disease Treatment Changing? October 27, 2014 Beta-blockers have been a universal treatment throughout the Cardiovascular Continuum1 for decades. They are a mainstay in the treatment of hypertension, stable ischemic heart disease, post-myocardial infarction (MI), heart failure, and in sympathetic-mediated tachyarrhythmias. A recent ...


October 27th, 2014

Oral Inosine a Potential Disease-Modifying Therapy for Parkinson’s

Oral Inosine a Potential Disease-Modifying Therapy for Parkinson's December 24, 2013 NEW YORK - In a study of patients with early Parkinson's disease (PD), oral inosine treatment raised serum and cerebrospinal fluid (CSF) urate levels, demonstrated nonfutility for slowing disability and was generally safe and well tolerated. Results of the ...


October 27th, 2014

ProSavin May Benefit Patients with Advanced Parkinson’s Disease

ProSavin May Benefit Patients with Advanced Parkinson's Disease January 30, 2014 NEW YORK - Patients with advanced Parkinson's disease may have improved motor responses with ProSavin, a lentiviral vector-based gene therapy, according a phase 1/2 open-label trial. ProSavin, designed to restore local and continuous dopamine production in those patients, was ...


October 27th, 2014

Levodopa Better First Parkinson’s Drug than MAO Inhibitors or Dopamine Agonists

Levodopa Better First Parkinson's Drug than MAO Inhibitors or Dopamine Agonists June 25, 2014 NEW YORK - Patients with newly diagnosed Parkinson's disease do better on patient-rated mobility scores if they receive levodopa instead of a levodopa-sparing therapy, new research suggests. The benefits are very small but persistent, and of ...


October 27th, 2014

Parkinson’s Drugs Linked to Impulse Control Disorders

Parkinson's Drugs Linked to Impulse Control Disorders October 20, 2014 NEW YORK - Dopamine receptor agonist drugs were linked with higher risks for pathological gambling, hypersexuality and compulsive shopping in a new study. Cases of these severe impulse control disorders linked to the drugs have been reported for more than ...